Gotop Logo

References

  1. Frohrib DA, Goldstein I, Payton TR, Padma-Nathan H, Krane RJ : Characterization of penile erectile states using external computer-based monitoring. Journal of Biomedical Engineering 1987; 1099(3): p 110.
  2.  
  3. Kaneko S, Bradley WE : Evaluation of erectile dysfunction with continuous monitoring of penile rigidity. Journal of Urology 1986; 136(11): p 1026.
  4.  
  5. Giesbers AAGM, Bruins JL, Kramer AEJL, Jonas U : New methods in the diagnosis of impotence : RigiScan penile tumescence and rigidity monitoring and diagnostic papaverine hydrochloride injection. World Journal of Urology 1987; 175(5): p 173.
  6.  
  7. Kessler WO : Nocturnal penile tumescence. Urologic Clinics of North America 1988; 15(2): p 81.
  8.  
  9. Lakin MM, Montague DK : Intracavernous injection therapy in post-priapism cavernosal fibrosis. Journal of Urology 1988; 140(10): p 828.
  10.  
  11. Weinberg JJ, Badlani GH : Utility of RigiScan and papaverine in diagnosis of erectile impotence. Urology 1988; 31(6): p 526.
  12.  
  13. Zeidman J, Raz S, Ehrlich RM: Spurious impotence after hypospadias repair. Urology 1989; 33(4): p 300.
  14.  
  15. Burris AS, Banks SM, Sherins RJ: Quantitative basement of nocturnal penile tumescence and rigidity in normal men using a home monitor. Journal of Andrology 1989; 10(11): p 492.
  16.  
  17. Fein RL: Classification of sexual dysfunction for management of intracavernous medication-induced erections. Journal of Urology 1990; 143(2): p 298.
  18.  
  19. Montague DK, Lakin MM, Vanderbrug MS, Tesar LJ: Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction. Journal of Urology 1991; 145(4): p 768.
  20.  
  21. Levine LA, Carroll RA: Nocturnal penile tumescence and rigidity in men without complaints of erectile dysfunction using new quantitative analysis software. Journal of Urology 1994; 152(10): p 1103.
  22.  
  23. Levine LA, Facs and Lencing EL: Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Urologic Clinics of North America 1995; 22(11): p 775.
  24.  
  25. Ogrinc F and Linet O: Evaluation of real-time Rigiscan monitoring in pharmacological erection. The Journal of Urology 1995; 154(10): p 1356.
  26.  
  27. Bradley WE ,Gerald W, Timm, Gallagher JM, Johnson BK: New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology 1985; 26(7): p 4.
  28.  
  29. Soh I, Naya Y, Ushijima S, Naitoh Y, Ochiai A, Mizutani Y, Kawauchi A, and Miki T, Fujiwara T: Efficacy of sildenafil for Iapanese patients with audio-visual sexual stimulation (avss) test by the Rigiscan Plus. Archives of Andrology 2006; 52: p 163.
  30.  
  31. Klotz L,* Heaton J, Jewett M, Chin J, Fleshner N, Goldenberg L and Gleave M: A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy. The Journal of Urology 2000; 164(11): p 1573.
  32.  
  33. Benet AE, Holcomb RJ and Melman A: The correlation between the new Rigiscan Plus software and the final diagnosis in the evaluation of erectile dysfunction. The Journal of Urology 1996; 156(12): p 1947.
  34.  
  35. Djmilian Mohamad , Stief C, Hartmann and Jonas U: Predictive value of real-time Rigiscan monitoring for the etiology of organogenic impotence. The Journal of Urology 1993; 149(5): p 1269.
  36.  
  37. Bradley WE : New techniques in evaluation of impotence. Urology 1987; 29(4): p 383.
  38.  
  39. Yaman O, Soygür T, Akand M, Tokatli Z: Effects of penile size on nocturnal erection evaluation with NPTR testing with men having micropenis. International Journal of Impotence Research 2005; 17(5):    p 243-7.
  40.  
  41. Incirci M, Ucer O, Comparison of audiovisual sexual stimulation test with nocturnal penile tumescence test in the evaluation of erectile dysfunction by using RigiScan. Turkish Journal of Urology 2010; 36(3): p 258-262.
  42.  
  43. Elhanbly S, Elkholy A, Nocturnal penile erections: the role of RigiScan in the diagnosis of vascular erectile dysfunction. Journal of Sexual Medicine  2012; 9(12): p 3219-3226.
  44.  
  45. Ogrinc F, Linet O, Evaluation of real-time RigiScan monitoring in pharmacological erection. Journal of Urology 1995; 154(4): p 1356-1359.
  46.  
  47. Bax G, Marin N, RigiScan evaluation of specific nervous impairment in patients with diabetes and erectile disorders. Diabetes Care 1998; 21(7): p 1159-1161.
  48.  
  49. Basar M, Atan A, New concept parameters of RigiScan in differentiation of vascular erectile dysfunction: Is it a useful test?  International Journal of Urology 2001; 8(12): p 686-691
  50.  
  51. Salonia A, Barbieri L, Comparison of the effect of Sildenafil and apomorphine SL on nocturnal erections in healthy volunteers: A placebo-controlled study. European Urology 2005; 47(1): p 524-529.
  52.  
  53. Carani C, Granata A, The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response to visual erotic stimuli in hypogonadal men. Psychoneuroendocrinology 1995; 20(7): p 743-753.
  54.  
  55. Hatzichristou D, Hatzimouratidis K, Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. Journal of Urology 1998; 159(6): p 1921-1926.
  56.  
  57. Pagani E, Glina E, Anxiety and high plasma catecholamines do not impair pharmaco-induced   erection of psychogenic erectile dysfunction patients. International Journal of Impotence Research 2003; 15(2): p 282-286.
  58.  
  59. Yanan O, Tokatli Z, Characteristics of Sildenafil erections in healthy young men. Asian Journal of Andrology 2005; 7(4): p 395-398.
  60.  
  61. Mizono I, Fuse H, Snap-Gauge band compared to RigiScan Plus in a nocturnal penile tumescence study for evaluation of erectile dysfunction. Urology International 2003; 71(1): p 96-99.

RigiScan® is the registered trademark of GOTOP Medical, Inc.,   Copyright 2014 GOTOP Medical, Inc. All Rights Reserved.